Notice names this product. Leading Pharma’s Furosemide Tablets is named in FDA Class II recall D-0486-2026. Your particular item is not yet verified. Compare the identifiers and exclusions in the notice before deciding whether it applies. Agency-reported hazard: CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. Identifying details: Lots# H03125, H03225, H03325, Exp Date: 2027/08. Units affected: 9384 bottles. Status: Ongoing.
This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.
Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.
If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.
CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
Company / brand: Leading Pharma recalls
Affected product: Furosemide Tablets recall status
Official ID D-0486-2026 · Official record ↗
See all Leading Pharma recalls →
Found something wrong or missing? Report a data error.
Compiled from connected official public-domain government data. Sources last checked October 22, 2026 at 6:00 PM UTC.